Sign in to view content

Impact of Race on Vision Outcomes in RanibizumabTreated Patients With Diabetic Macular Edema: A Meta-Analysis of 5 Clinical Trial

M. Ali Khan, MD, FACS, FASRS

Video
Published 2021

Related

Suprachoroidal CLS-TA Plus Aflibercept Compared With Aflibercept Monotherapy for DME: Results of a Phase 2 Trial
Michael S. Ip, MD
Annual Meeting Talks
2019
Outcomes of Intravitreal Antivascular Endothelial Growth Factor (VEGF) Therapy for Diabetic Macular Edema in Routine Clinical Practice
John D Pitcher, MD
Annual Meeting Talks
2018
Two years visual acuity and anatomical outcomes of patients with diabetic macular oedema treated with intravitreal aflibercept in a real life setting
Marko Lukic, MD PhD FEBO FASRS
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more